Free Access
| Issue |
Med Sci (Paris)
Volume 34, Number 10, Octobre 2018
|
|
|---|---|---|
| Page(s) | 765 - 768 | |
| Section | Le Magazine | |
| DOI | https://doi.org/10.1051/medsci/2018201 | |
| Published online | 19 November 2018 | |
- Guignabert C, Tu L, Girerd B, et al. New molecular targets of pulmonary vascular remodeling in pulmonary arterial hypertension: importance of endothelial communication. Chest 2015 ; 147 : 529–537. [CrossRef] [PubMed] [Google Scholar]
- Perros F, Humbert M, Cohen-Kaminski S, Hypertension pulmonaire artérielle : un parfum d’auto-immunité. Med Sci (Paris) 2013 ; 29 : 607–616. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
- Cracowski JL, Chabot F, Labarere J, et al. Proinflammatory cytokine levels are linked to death in pulmonary arterial hypertension. Eur Respir J 2014 ; 43 : 915–917. [CrossRef] [PubMed] [Google Scholar]
- Soon E, Holmes AM, Treacy CM, et al. Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension. Circulation 2010 ; 122 : 920–927. [CrossRef] [PubMed] [Google Scholar]
- Humbert M, Monti G, Brenot F, et al. Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension. Am J Respir Crit Care Med 1995 ; 151 : 1628–1631. [CrossRef] [PubMed] [Google Scholar]
- Ricard N, Tu L, , Le Hiress M, et al. Increased pericyte coverage mediated by endothelial-derived fibroblast growth factor-2 and interleukin-6 is a source of smooth muscle-like cells in pulmonary hypertension. Circulation 2014 ; 129 : 1586–1597. [CrossRef] [PubMed] [Google Scholar]
- Savale L, Tu L, Rideau D, et al. Impact of interleukin-6 on hypoxia-induced pulmonary hypertension and lung inflammation in mice. Respir Res 2009 ; 10 : 6. [CrossRef] [PubMed] [Google Scholar]
- Tamura Y, Phan C, Tu L, et al. Ectopic upregulation of membrane-bound IL6R drives vascular remodeling in pulmonary arterial hypertension. J Clin Invest 2018 ; 128 : 1956–1970. [CrossRef] [PubMed] [Google Scholar]
- Golembeski SM, West J, Tada Y, Fagan KA. Interleukin-6 causes mild pulmonary hypertension and augments hypoxia-induced pulmonary hypertension in mice. Chest 2005 ; 128 : S572–S573. [CrossRef] [Google Scholar]
- Steiner MK, Syrkina OL, Kolliputi N, et al. Interleukin-6 overexpression induces pulmonary hypertension. Circ Res 2009; 104 : 236–44, 28p following 44. [CrossRef] [Google Scholar]
- Le Hiress M, Tu L, Ricard N, et al. Proinflammatory signature of the dysfunctional endothelium in pulmonary hypertension. Role of the macrophage migration inhibitory factor/CD74 complex. Am J Respir Crit Care Med 2015 ; 192 : 983–997. [CrossRef] [PubMed] [Google Scholar]
- Hashimoto-Kataoka T, Hosen N, Sonobe T, et al. Interleukin-6/interleukin-21 signaling axis is critical in the pathogenesis of pulmonary arterial hypertension. Proc Natl Acad Sci USA 2015 ; 112 : E2677–E2686. [CrossRef] [Google Scholar]
- Jasiewicz M, Knapp M, Waszkiewicz E, et al. Enhanced IL-6 trans-signaling in pulmonary arterial hypertension and its potential role in disease-related systemic damage. Cytokine 2015 ; 76 : 187–192. [CrossRef] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.